ST. BALDRICK’S FOUNDATION is providing infrastructure grants to nearly 40 childhood cancer institutions across the U.S., allowing them to conduct research and increase the number of children participating in clinical trials. A joint program was created from three Chicago institutions, with the support of St. Baldrick’s infrastructure grants, to enroll patients on Children’s Oncology Group...
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
